These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11899400)

  • 1. Prodrugs.
    Backes WL
    Clin J Oncol Nurs; 2001; 5(1):35. PubMed ID: 11899400
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor-specific activation of prodrugs: is there a role for nuclear medicine?
    Antunes IF; Haisma HJ; de Vries EF
    Nucl Med Commun; 2008 Oct; 29(10):845-6. PubMed ID: 18769302
    [No Abstract]   [Full Text] [Related]  

  • 3. Paclitaxel prodrugs: toward smarter delivery of anticancer agents.
    Skwarczynski M; Hayashi Y; Kiso Y
    J Med Chem; 2006 Dec; 49(25):7253-69. PubMed ID: 17149855
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peroral fluoropyrimidines in chemotherapy for malignant tumors].
    Semiglazova TIu; Gershanovich ML
    Vopr Onkol; 2001; 47(4):388-95. PubMed ID: 11710276
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor targeting: activation of prodrugs by enzyme-monoclonal antibody conjugates.
    Huennekens FM
    Trends Biotechnol; 1994 Jun; 12(6):234-9. PubMed ID: 7765070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ethylene glycol) anticancer drug delivery systems.
    Greenwald RB
    P R Health Sci J; 2002 Jun; 21(2):113-21. PubMed ID: 12166021
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular therapy for cancer.
    Deisseroth A; Guo D; Wang T; Fujii T; Fu SQ; Cote R; Savinov S; Liu F; Loewe R; Pizzorno G; Austin D; Crystal R; Chung I
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S5-7. PubMed ID: 9619264
    [No Abstract]   [Full Text] [Related]  

  • 8. Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs.
    Takakura Y; Hashida M
    Crit Rev Oncol Hematol; 1995 Mar; 18(3):207-31. PubMed ID: 7695833
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin C and cancer revisited.
    Frei B; Lawson S
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11037-8. PubMed ID: 18682554
    [No Abstract]   [Full Text] [Related]  

  • 10. Do prodrugs deliver?
    Smith DA
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):550-9. PubMed ID: 17786853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioreductive prodrugs for cancer therapy.
    Seddon B; Kelland LR; Workman P
    Methods Mol Med; 2004; 90():515-42. PubMed ID: 14657582
    [No Abstract]   [Full Text] [Related]  

  • 12. Exploiting Enzyme Alterations in Cancer for Drug Activation, Drug Delivery, and Nanotherapy.
    Hayashi JY; Tamanoi F
    Enzymes; 2017; 42():153-172. PubMed ID: 29054269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the molecular basis for tumour hypoxia.
    Carroll VA; Ashcroft M
    Expert Rev Mol Med; 2005 Apr; 7(6):1-16. PubMed ID: 15831177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-directed enzyme/prodrug therapy (ADEPT).
    Bagshawe KD
    Biochem Soc Trans; 1990 Oct; 18(5):750-2. PubMed ID: 2083666
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of pro-drug therapy in the treatment of cancer.
    Ferguson MJ; Ahmed FY; Cassidy J
    Drug Resist Updat; 2001 Aug; 4(4):225-32. PubMed ID: 11991677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part I.
    Kneller S
    IDrugs; 2007 Jun; 10(6):356-8. PubMed ID: 17641993
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro and in vivo models for evaluation of GDEPT: quantifying bystander killing in cell cultures and tumors.
    Wilson WR; Pullen SM; Hogg A; Hobbs SM; Pruijn FB; Hicks KO
    Methods Mol Med; 2004; 90():403-31. PubMed ID: 14657576
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances with monoclonal antibody drug targeting for the treatment of human cancer.
    Koppel GA
    Bioconjug Chem; 1990; 1(1):13-23. PubMed ID: 2095201
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular imaging as a tool for personalized and targeted anticancer therapy.
    McLarty K; Reilly RM
    Clin Pharmacol Ther; 2007 Mar; 81(3):420-4. PubMed ID: 17339871
    [No Abstract]   [Full Text] [Related]  

  • 20. Prodrug strategies in anticancer chemotherapy.
    Kratz F; Müller IA; Ryppa C; Warnecke A
    ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.